Mogo’s WonderFi Stake Set for Monetization Following Shareholder Approval of Robinhood Acquisition
Paves the way for expanded Bitcoin treasury strategy and strategic investments in Mogo’s digital finance platform VANCOUVER, British Columbia–(BUSINESS WIRE)–Mogo... Read more.
Onto Innovation to Report Second Quarter 2025 Financial Results on August 7, 2025
WILMINGTON, Mass.–(BUSINESS WIRE)–$ONTO–Onto Innovation Inc. (NYSE: ONTO) will release its 2025 second quarter results shortly after the market... Read more.
Intermediate Age-Related Macular Degeneration Market Research 2025-2035 Featuring Novartis, Allegro Ophthalmics, and Apellis Pharmaceuticals – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intermediate Age-Related Macular Degeneration Market – A Global and Regional Analysis: Analysis and Forecast,... Read more.
Security 101 Named #8 Top Systems Integrator by SDM Magazine
Franchise Partner True Security Also Recognized at #75 WEST PALM BEACH, Fla.–(BUSINESS WIRE)–#Security101–Security 101, a national leader in commercial... Read more.
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution
Growing our Portfolio to Twenty-Five Products EAST BRUNSWICK, N.J.–(BUSINESS WIRE)–Cronus Pharma LLC, a fully integrated research, development, manufacturing,... Read more.
IonQ Expands Engineering Leadership Team, Hiring Rick Muller as Vice President of Quantum Systems
Former director of the Intelligence Advanced Research Projects Activity (IARPA) brings decades of R&D leadership and systems engineering expertise to accelerate... Read more.
LongRange Capital Completes Acquisition of US Synthetic
STAMFORD, Conn.–(BUSINESS WIRE)–LongRange Capital (“LongRange”), a private equity firm with a longer-term, customer-centric orientation to building... Read more.
The IMA Group Acquires New York’s Medical Research Network
IMA Clinical Research continues to grow; acquisition adds CNS research site in NYC and expands access to promising clinical trials to patients in high-need therapeutic... Read more.
TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer
Longer-term follow up in the FLAURA2 Phase III trial confirms the favorable benefit-risk profile of this combination Overall survival results reinforce TAGRISSO... Read more.
BKV Corp. Expands Strategic Partnership with Leading Midstream Operator to Advance Carbon Capture and Sequestration Development
DENVER–(BUSINESS WIRE)–BKV Corporation (“BKV” or the “Company”) (NYSE: BKV) today announced the execution of an agreement with a leading diversified... Read more.